Experience

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.3 billion of senior notes. The offering consisted of two tranches of senior notes,…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of its 3.625% senior notes due 2030. The notes are guaranteed by…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Bandwidth Inc. of an aggregate principal amount of $400 million of its 0.25% convertible senior…

Davis Polk advised the underwriters on an SEC-registered offering by W.W. Grainger of $500 million aggregate principal amount of 1.85% senior notes due 2025. Headquartered in Lake Forest,…

Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…

Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…

Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $750 million aggregate principal amount of 2.950% notes due 2029 and $1.25 billion aggregate principal…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $224.3 million offering of common stock of Constellation…

Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $45 million SEC-registered common stock and pre-funded warrants offering…